West Oakland's 16th Street Station joins the National Register, celebrating African American migration, labor history and ...

Background and goal: Managing type 2 diabetes involves complex treatment, workload, and costs that impose a significant burden on individuals, impacting their physical and mental health.

With metabolic disorders like obesity and diabetes reaching epidemic proportions, scientists are exploring new biological mechanisms that regulate metabolism beyond just diet and exercise.

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA ...

Police and ambulance rushed to the house and found Jamie, 37, unconscious and barely breathing following the life-threatening diabetic attack. On Tuesday, the North East Ambulance Service visited ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday. Roanna Ruiz’s rating is based on the promising outlook for Lexicon ...

BRISBANE, Australia — Two bereaved parents and 12 fellow members of an Australian religious congregation accused of killing an 8-year-old girl by withholding her diabetes medication were found ...

Ambulance bosses have released the emergency phone call from an eight-year-old boy who saved his dad’s life after he fell into diabetic coma ... North East Ambulance Service’s dispatch ...

Diabetes is a number of diseases that involve problems with the hormone insulin. There is no cure for diabetes. The warning signs of diabetes can be so mild that you don't notice them. That's ...

Ozempic is a medication originally approved for type 2 diabetes but is often used off-label for weight loss. When people lose weight rapidly, they may also lose fat from their face, leading to a ...

Elizabeth Rose Struhs died at her family’s house in the southern Australian city of Toowoomba after being denied her insulin shots for type-1 diabetes for six days. Her parents, Jason Richard ...

In advance of topline data from the Phase 2b PROGRESS trial anticipated later this quarter, the event will offer an in-depth overview on LX9211 for the treatment of diabetic peripheral neuropathic ...